Global Genome Sequencing Market 2024

Global Genome Sequencing Market 2024

The global genome sequencing market is anticipated to increase by USD 9.6 billion till 2030 at an average annual growth of 12.7 percent as per the latest market estimates. The genome sequencing market is expanding as advancements in technology drive down costs, making sequencing more accessible for research and clinical applications. Increased demand for personalized medicine is also fueling growth, with healthcare providers leveraging genomic data to tailor treatments and improve patient outcomes. Additionally, government initiatives and funding for genomics research are bolstering the market, encouraging further innovation and the development of new sequencing techniques.

This comprehensive industry report provides market estimates and forecasts, accompanied by a detailed examination of the product, type, technology, end user, and region aspects. It delivers a quantitative analysis of the market, empowering stakeholders to leverage existing market opportunities. Furthermore, the report identifies key segments for potential opportunities and strategies, drawing insights from market trends and the approaches of leading competitors.

The global genome sequencing market has been extensively analyzed by categorizing it according to various sub-segments in order to provide accurate forecasts of industry size and assess trends within specific areas.

The global market for genome sequencing can be segmented by product: instruments, kits, software.

Genome sequencing market is further segmented by type: RNA sequencing (RNA-Seq), targeted sequencing, whole exome sequencing (WES), whole genome sequencing (WGS).

Based on technology, the genome sequencing market is segmented into: first-generation sequencing, next-generation sequencing (NGS), third-generation sequencing.

On the basis of end user, the genome sequencing market also can be divided into: academic and research institutions, diagnostic laboratories, pharmaceutical and biotechnology companies, others.

Genome sequencing market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

The market research report covers the analysis of key stake holders of the global genome sequencing market. Some of the leading players profiled in the report include 10x Genomics, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, BGI Genomics Co., Ltd., Element Biosciences, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina, Inc., MGI Tech Co., Ltd., MicroGen Diagnostics, LLC, OncoDNA SA, Oxford Nanopore Technologies plc, Pacific Biosciences of California, Inc., PerkinElmer, Inc., Phase Genomics Inc., Qiagen N.V., Revvity, Inc., Thermo Fisher Scientific Inc., Ultima Genomics, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Why Choose This Report

Gain a reliable outlook of the global genome sequencing market forecasts from 2024 to 2030 across scenarios.

Identify growth segments for investment.

Stay ahead of competitors through company profiles and market data.

The market estimate for ease of analysis across scenarios in Excel format.

Strategy consulting and research support for three months.

Print authentication provided for the single-user license.

Market Segments Covered in Global Genome Sequencing Industry Analysis:

i.) Product

• Instruments
• Kits
• Software

ii.) Type

• RNA sequencing (RNA-Seq)
• Targeted sequencing
• Whole exome sequencing (WES)
• Whole genome sequencing (WGS)

iii.) Technology

• First-generation sequencing
• Next-generation sequencing (NGS)
• Third-generation sequencing

iv.) End user

• Academic and research institutions
• Diagnostic laboratories
• Pharmaceutical and biotechnology companies
• Others

v.) Region

• North America
• Europe
• Asia-Pacific
• MEA (Middle East and Africa)
• Latin America